Google
GNTA — GENENTA SCIENCE SPA ADR (Healthcare >> Biotechnology)
GNTA FAQ
What is GNTA's ROE?
GENENTA SCIENCE SPA ADR reports a Return on Equity (ROE) of -70.57%.
What is GNTA's dividend yield?
GENENTA SCIENCE SPA ADR offers a dividend yield of 0.00%.
What is GNTA's Deepscope Quality Score?
Deepscope rates GNTA's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GNTA?
Deepscope's AI Timing Score for GNTA is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GNTA belong to?
GENENTA SCIENCE SPA ADR is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.04
Price
0.08
(4.08%)
Day Change
|
|
|---|
GNTA, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.04 |
| PBV / Sector |
2.27 / 4.63
|
| Earning Per Share | -0.63 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
6.71 M
|
| Average 1W Daily Value |
25.06 M
GREAT
|
| Timing Factors |
|
100% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:45 |
| Symbol | GNTA |
| Name | GENENTA SCIENCE SPA ADR |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 23.59 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 49.54 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Via Olgettina No. 58, Milan, MI, Italy, 20132
Phone: 39 02 26434681
Website: https://www.genenta.com
Sector: Healthcare >> Biotechnology
Description: Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
